Welcome to the new Independent website. We hope you enjoy it and we value your feedback. Please contact us here.

380 jobs set to go at GlaxoSmithKline

Drugs giant GlaxoSmithKline is to cut up to a third of jobs at one of its UK research and development sites, it was learned today.

A 90-day consultation has started with workers at the site in Harlow, Essex, which employs 1,150, raising the threat of up to 380 job losses.

The company reported a 12 per cent rise in annual profits last week but stressed the need to reduce costs, reviving fears of big job cuts.

Pre-tax profits for 2009 were £8.73 billion, but the firm announced plans to expand its restructuring programme to deliver another £500 million of savings by 2012.

Chief executive Andrew Witty said last week: "I believe that our strategy is delivering and GSK's long-term prospects are improving."